BioWorld-International-2010-06-30
BI to Provide Sales Heft to Marinomed's Cold Spray Drug
BI to Provide Sales Heft to Marinomed's Cold Spray Drug
Marinomed Biotechnologie GmbH is banking an undisclosed up-front payment of several million Euros on the back of a distribution deal it has entered with Boehringer Ingelheim GmbH involving its antiviral nasal spray for the common cold. (BioWorld International)

